Hookipa Biotech AG, headquartered in Austria, is a pioneering company in the biotechnology sector, specialising in innovative immunotherapies for cancer treatment. Founded in 2011, Hookipa has made significant strides in the development of its proprietary platform, which harnesses the power of viral vectors to stimulate robust immune responses against tumours. With a focus on advancing its lead product candidates, Hookipa's unique approach combines cutting-edge science with a commitment to improving patient outcomes. The company has established a strong market position, recognised for its groundbreaking research and development efforts in the field of oncolytic immunotherapy. As it continues to expand its operational reach, Hookipa Biotech AG remains dedicated to transforming cancer care through its novel therapeutic solutions.
We don't have data for Hookipa Biotech AG, but we can show you information about their parent organization instead.
View parent company